RxDoctor Payments Data

Uzoma Anele, MD

Urology · Louisville, KYNPI 1851788848

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $60,269 with a category attached, or 83.0%. Boston Scientific accounts for 95.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $50,139 and has fallen 95.7% since, to $2,137 in 2025. Among urology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,269in general payments, 2019–2025

Across 110 payments — averaging $547.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$57K
  • Coloplast$1K
  • Endo Pharmaceuticals Inc.$429
  • Bayer$223
  • Edwards Lifesciences$114
  • Innovation Technologies Inc$107
  • plus $513 from 14 others

What the payments were for

  • Consulting fees$4501%
  • Grants$50,00083%
  • Travel & lodging$4,4867%
  • Food & beverage$5,2419%
  • Education$910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,269 in reported general payments places this provider in the 95th percentile of 139 urology providers in Kentucky.

See all urology providers in Kentucky

Medicare billing

Part B allowed, 2024
$106,980
Medicare patients
186
Services billed
1,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Testosterone Cypionate38$938
Finasteride51$415
Tamsulosin Hcl42$311
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$143
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$32

Paid to pharmacies, not to this prescriber.

Other urology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →